[New Product] Completion of Development and Launch of VEGF Alternative Peptide (VEGFR2 Agonist)
2023/09/05
We have successfully developed a peptide that demonstrates high selectivity and agonist activity against VEGFR2, similar to VEGF. Starting from September 2023, we will start selling the VEGF Alternative Peptide (VEGFR2 Agonist) under the product code "PG-007".
PG-007 is intended to be used in the field of regenerative medicine and organoids for constructing vascular structures within organ tissue and as a differentiation-inducing factor for hematopoietic stem cells derived from iPS cells.
We can provide the free sample. Please feel free to contact us from [Contact].
